Association between genetic variants in genes encoding Argonaute proteins and cancer risk: A meta-analysis

Pathology - Research and Practice - Tập 216 - Trang 152906 - 2020
Zorana Dobrijević1, Suzana Matijašević2, Dušanka Savić-Pavićević2, Goran Brajušković2
1Department for Metabolism, Institute for the Application of Nuclear Energy (INEP), University of Belgrade, Belgrade, Serbia
2Centre for Human Molecular Genetics, Faculty of Biology, University of Belgrade, Belgrade, Serbia

Tài liệu tham khảo

GBD 2017 Causes of Death Collaborators, 2018, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017, Lancet, 392, 1736, 10.1016/S0140-6736(18)32203-7 Prager, 2018, Global cancer control: responding to the growing burden, rising costs and inequalities in access, ESMO Open, 3, 10.1136/esmoopen-2017-000285 Esteller, 2011, Non-coding RNAs in human disease, Nat Rev Genet., 12, 861, 10.1038/nrg3074 Nana-Sinkam, 2011, MicroRNAs as therapeutic targets in cancer, Transl Res., 157, 216, 10.1016/j.trsl.2011.01.013 Reddy, 2015, MicroRNA (miRNA) in cancer, Cancer Cell Int., 15, 38, 10.1186/s12935-015-0185-1 Romano, 2017, Small non-coding RNA and cancer, Carcinogenesis., 38, 485, 10.1093/carcin/bgx026 Lai, 2016, Understanding microRNA-mediated gene regulatory networks through mathematical modelling, Nucleic Acids Res., 44, 6019, 10.1093/nar/gkw550 Peng, 2016, The role of MicroRNAs in human cancer, Signal Transduct Target Ther., 1, 15004, 10.1038/sigtrans.2015.4 Wilk, 2018, Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer, Nucleic Acids Res., 46, 1089, 10.1093/nar/gkx1250 Cenik, 2011, Argonaute proteins, Curr Biol., 21, R446, 10.1016/j.cub.2011.05.020 Nakanishi, 2016, Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins?, Wiley Interdiscip Rev RNA, 7, 637, 10.1002/wrna.1356 Ruda, 2014, The roles of individual mammalian argonautes in RNA interference in vivo, PLoS One, 9, 10.1371/journal.pone.0101749 Liu, 2018, Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer, Mol Cancer., 17, 64, 10.1186/s12943-018-0765-5 Li, 2010, Argonaute proteins: potential biomarkers for human colon cancer, BMC Cancer, 10, 38, 10.1186/1471-2407-10-38 Sand, 2012, Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer, Mol Carcinog., 51, 916, 10.1002/mc.20861 Ye, 2015, Argonaute 2: A Novel Rising Star in Cancer Research, J Cancer, 6, 877, 10.7150/jca.11735 Völler, 2016, Argonaute Family Protein Expression in Normal Tissue and Cancer Entities, PLoS One, 11, 10.1371/journal.pone.0161165 Parisi, 2011, Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells, FEBS Lett., 585, 2965, 10.1016/j.febslet.2011.08.003 Zhang, 2013, Overexpression of human Argonaute2 inhibits cell and tumor growth, Biochim Biophys Acta., 1830, 2553, 10.1016/j.bbagen.2012.11.013 Wang, 2018, AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway, Cell Death Dis., 9, 324, 10.1038/s41419-018-0338-y Ryan, 2010, Genetic variation in microRNA networks: the implications for cancer research, Nat Rev Cancer, 10, 389, 10.1038/nrc2867 Guo, 2016, Identification of diagnostic and prognostic biomarkers for cancer: Focusing on genetic variations in microRNA regulatory pathways (Review), Mol Med Rep., 13, 1943, 10.3892/mmr.2016.4782 Wallace, 2012, Closing the gap between methodologists and end-users: R as a computational back-end, J. Stat. Softw., 49, 1, 10.18637/jss.v049.i05 Martorell-Marugan, 2017, MetaGenyo: a web tool for meta-analysis of genetic association studies, BMC Bioinformatics, 18, 563, 10.1186/s12859-017-1990-4 Mantel, 1959, Statistical aspects of the analysis of data from the retrospective analysis of disease, J Natl Cancer Inst.., 22, 719 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 77, 10.1016/0197-2456(86)90046-2 Gutierrez-Camino, 2014, Noncoding RNA-related polymorphisms in pediatric acute lymphoblastic leukemia susceptibility, Pediatr Res., 75, 767, 10.1038/pr.2014.43 Horikawa, 2008, Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma, Clin Cancer Res., 14, 7956, 10.1158/1078-0432.CCR-08-1199 Yang, 2008, Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer, Cancer Res., 68, 2530, 10.1158/0008-5472.CAN-07-5991 Kim, 2010, Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study, Mol Carcinog., 49, 913, 10.1002/mc.20672 Martin-Guerrero, 2015, Genetic variants in miRNA processing genes and pre-miRNAs are associated with the risk of chronic lymphocytic leukemia, PLoS One, 10, 10.1371/journal.pone.0118905 Nikolić, 2017, Genetic variants in RNA-induced silencing complex genes and prostate cancer, World J Urol., 35, 613, 10.1007/s00345-016-1917-0 Sung, 2011, Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea, Breast Cancer Res Treat., 130, 939, 10.1007/s10549-011-1656-2 Jiang, 2013, Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women, Int J Cancer, 133, 2216, 10.1002/ijc.28237 Mullany, 2016, Impact of polymorphisms in microRNA biogenesis genes on colon cancer risk and microRNA expression levels: a population-based, case-control study, BMC Med Genomics, 9, 21, 10.1186/s12920-016-0181-x Permuth-Wey, 2011, Ovarian Cancer Association Consortium, LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer, Cancer Res., 71, 3896, 10.1158/0008-5472.CAN-10-4167 Li, 2015, Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis, BMC Cancer, 15, 862, 10.1186/s12885-015-1895-4 Fang, 2016, Polymorphisms in GEMIN4 and AGO1 genes are associated with the risk of lung cancer: a case-control study in Chinese female non-smokers, Int J Environ Res Public Health, 13, E939, 10.3390/ijerph13100939 Peckham-Gregory, 2016, MicroRNA-related polymorphisms and non-Hodgkin lymphoma susceptibility in the Multicenter AIDS Cohort Study, Cancer Epidemiol., 45, 47, 10.1016/j.canep.2016.09.007 Song, 2017, Association between SNPs in microRNA machinery genes and gastric cancer susceptibility, invasion, and metastasis in Chinese Han population, Oncotarget, 8, 86435, 10.18632/oncotarget.21199 Cooper, 2010, Functional intronic polymorphisms: Buried treasure awaiting discovery within our genes, Hum Genomics, 4, 284, 10.1186/1479-7364-4-5-284 Karakas, 2017, Regulating the regulators in Attention-Deficit/Hyperactivity disorder: a genetic association study of microRNA biogenesis pathways, OMICS., 21, 352, 10.1089/omi.2017.0048 Gedik, 2015, Association of microRNA biogenesis pathway gene variants and alcohol dependence risk, DNA Cell Biol., 34, 220, 10.1089/dna.2014.2549 He, 2012, Genetic variations in microRNA processing genes are associated with susceptibility in depression, DNA Cell Biol., 31, 1499, 10.1089/dna.2012.1660 Shang, 2014, Association between SNPs in miRNA-machinery genes and chronic hepatitis B in the Chinese Han population, Infect Genet Evol., 28, 113, 10.1016/j.meegid.2014.09.015 Song, 2013, Association between SNPs in microRNA-machinery genes and tuberculosis susceptibility in Chinese Tibetan population, Mol Biol Rep., 40, 6027, 10.1007/s11033-013-2712-2 Bilbao-Aldaiturriaga, 2015, Polymorphisms in miRNA processing genes and their role in osteosarcoma risk, Pediatr. Blood Cancer, 62, 766, 10.1002/pbc.25416 Ye, 2008, Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk, Cancer Prev Res (Phila), 1, 460, 10.1158/1940-6207.CAPR-08-0135 Lin, 2012, Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients, Clin Cancer Res., 18, 3982, 10.1158/1078-0432.CCR-11-2951